HEALTH TECHNOLOGY ASSESSMENT FOR TREATMENT OF CHRONIC HEPATITIS C REIMBURSED BY PUBLIC HEALTH FUND IN BULGARIA, 2016
Journal Title: Българско списание за обществено здраве (Bulgarian Journal of Public Health) - Year 2016, Vol 0, Issue 3
Abstract
In this study there have been defined the direct costs of treatment of chronic hepatitis C (CHC) by protease inhibitors (Pi), NS5B inhibitors (NS5Bi), NS5A inhibitors (NS5Ai) and calculated the coefficient of efficiency of the additional costs (incremental cost-effectiveness ratio, ICER) per year, consistent with the quality of life (quality adjusted life year, QALY) in Bulgaria through transfer and adaptation of data from evaluations of Pi, NS5Bi, NS5Ai therapies to the local environment. The aim is to create pharmacotherapy guidance for treatment of CHC based on evidence, for comparative therapeutic efficacy and cost effectiveness of medicinal alternatives as the main approach to the management of public expenditure in Bulgaria. Material and methods. There has been made a systematic review of published data from analyses of the cost-effectiveness of Pi, NS5Bi, NS5Ai to treat CHC. Databases used are: MEDLINE, EMBASE, Web of Science, Cochrane Library. Literature search covers the period from January 2014 to July 2016. Data for health benefits in terms of additional QALY are directly transferred for the purposes of this analysis. Data on direct health care costs, associated with the treatment by Pi, NS5Bi, NS5Ai, are based on local reference prices in Bulgaria by August 2016. Results. The selection of published data on the costeffectiveness of Pi, NS5Bi, NS5Ai to treat CHC, identified 12 studies included in this analysis. The summarized analysis requires the following conclusions: 1. The use of combination drug therapies that do not involve Pegylated interferon (peginterferon, pegIFN), as SOF + LED and OMB + PAR + RIT ± DAS + R, is a cost non-effective approach compared with combination therapies containing peginterferon, in the treatment of patients with CHC (GT1,4 ± CIR. 2. In an indirect comparison of combination drug therapies presented in a pharmaceutical form (OMB/ PAR/RIT vs SOF/LED), used in combinations that do not include peginterferon, found that OMB/PAR/ RIT dominates SOF/LED with a better therapeutic outcomes and lower cost for treatment cycle (ΔQALY + 0,73; Δcosts - 7516 BGN). In conclusion, pharmacotherapy guidelines for the treatment of patients with CHC GT1,4 ± CIR in Bulgaria based on a comparative assessment of therapeutic efficacy, safety and pharmaco-economic indicators recommended as first therapeutic line the use of peginterferon, including combinations and only after failure as a second therapeutic line to use combination therapies as SOF/LED and OMB/PAR/RIT.
Authors and Affiliations
Tony Vekov, Petko Salchev
Keywords
Related Articles
- EP ID EP473865
- DOI -
- Views 80
- Downloads 0
NECESSITY-DRIVEN GUIDELINES FOR EVIDENCE-BASEDCLINICAL PRACTICE PART ONE METHODOLOGY FOR THE DEVELOPMENT OF GOOD CLINICAL PRACTICE GUIDELINES
The article presented is composed of two parts. The first part provides an overview of the types of Good clinical practice guidelines, their nature and includes the basic principles of medical ethics. It systematizes sta...
CURRENT TRENDS IN SUSTAINABLE MEDICINES MARKE
Price-gouging in the health care sector has attracted serious public attention and has become highly politicized in many jurisdictions. The ongoing EU Commission‘s probe into excessive pricing practices suggests that, at...
REFLECTIONS ON THE AESTHETIC, ETHICAL AND PSYCHOSOCIAL MERITS OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY
The author of the article considers that Plastic, Reconstructive and Aesthetic Surgery is a system clinical direction of "the System Surgery" and consequently of "the Mega system Healthcare". The article emphasizes that...
WEST NILE VIRUS MYOCARDITIS PRESENTING AS NON ST ELEVATION MYOCARDIAL INFARCTION
While most individuals infected with West Nile Virus (WNV) are asymptomatic, 20-40% of individuals infected with the virus show symptoms (1-4). Typical presentations of WNV infection include West Nile fever and neuroinva...
NUTRITIONAL RISK FACTORS FOR CHRONIC NON-COMMUNICABLE DISEASES IN INFANTS AND YOUNG CHILDREN IN SOFIA
The aim of the current study “Nutrition and nutritional status of infants and young children under five years of age in the city of Sofia” is to establish nutritional risk factors that influence the growth and health of...